Leerink Swann Raises Revenue, EPS Estimates for Illumina
April 08, 2011
Leerink Swann Raises Revenue, EPS Estimates for Illumina
Analyst Dan Leonard said growth will be driven by what he expects to be record-breaking sales of Illumina's next-generation sequencing platforms, including its HiSeq, in the first and second quarters of 2011.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Goldman Sachs Lowers Estimates on Illumina, But Favors MiSeq Growth Over PGM
June 24, 2011 / GenomeWeb Daily News - Illumina Names Several Partners for New TruSeq, Nextera Program
May 15, 2013 / GenomeWeb Daily News - Illumina Inks MDx Alliance with Chinese Diagnostics Services Firm
April 18, 2013 / GenomeWeb Daily News - New Desktop Sequencer Comparison Suggests 'Two-Horse Race' Between MiSeq, PGM
April 9, 2013 / In Sequence - Dilution-Based Illumina Method Allows for Targeted and Whole-Genome Haplotyping
March 26, 2013 / In Sequence